Breast Biopsy Market

Breast biopsy sales will strengthen through 2036, anchored by vacuum-assisted devices at 28.9% of the product segment in 2026, driven by sustained demand from core end-use applications and favorable procurement conditions. The market was valued at USD 2.63 billion in 2025 and is expected to be worth USD 4.41 billion by 2036.